Detecting T790M mutation of tissue and plasma ctDNA samples by ARMS in EGFR-mutant NSCLC patients after disease progression

被引：2
|
作者：
Wu, Ya-Lan
Tong, Rui-Zhan
Zhang, Yan
Hu, Bin -Bin
Zhen, Ke
Zhao, Qian
Zhou, Xiao-Juan
Ding, Zhen-Yu
Peng, Feng
Gong, You-Ling
Xu, Yong
Wang, Jin
Ren, Li
Liu, Yong-Mei
Lu, You
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20625
引用
收藏
页数：5
相关论文
共 50 条
  • [21] ROR1 AS A NOVEL THERAPEUTIC TARGET FOR EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH THE EGFR T790M MUTATION
    Karachaliou, Niki
    Drozdowskyj, Ana
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Gimenez-Capitan, Ana
    Vergnenegre, Alain
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Heidecke, Cordula
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Bivona, Trever
    Giannikopoulos, Petros
    Ono, Mayumi
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1048 - S1048
  • [22] Safety and Efficacy of Osimertinib in Treating an EGFR-Mutant Lung Cancer Patient with a Germline EGFR T790M Mutation
    Ma, W.
    Gong, J.
    Shan, J.
    Lewis, D.
    Xiao, W.
    Hung, J.
    Moore, E. H.
    Zhang, Y.
    Mans, N. Z.
    Welborn, J.
    Lam, K. S.
    Li, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1863 - S1864
  • [23] Shades of T790M: Intratumor Heterogeneity in EGFR-Mutant Lung Cancer
    Ichihara, Eiki
    Lovly, Christine M.
    CANCER DISCOVERY, 2015, 5 (07) : 694 - 696
  • [24] The role of T790M mutation in EGFR-TKI re-challenge for patients with EGFR-mutant advanced lung adenocarcinoma
    Zhang, Qiuyi
    Ke, Ee
    Niu, Feiyu
    Deng, Wei
    Chen, Zhihong
    Xu, Chongrui
    Zhang, Xuchao
    Zhao, Ning
    Su, Jian
    Yang, Jinji
    Yan, Honghong
    Wu, Yilong
    Zhou, Qing
    ONCOTARGET, 2017, 8 (03) : 4994 - 5002
  • [25] Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors
    Dogan, Izzet
    Khanmammadov, Nijat
    Paksoy, Nail
    Vatansever, Sezai
    Saip, Pinar
    Aydiner, Adnan
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (01) : 27 - 32
  • [26] Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
    Xu, Sanpeng
    Duan, Yaqi
    Lou, Liping
    Tang, Fengjuan
    Shou, Juan
    Wang, Guoping
    ONCOLOGY LETTERS, 2016, 12 (05) : 4238 - 4244
  • [27] Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation
    Watanabe, Kana
    Saito, Ryota
    Miyauchi, Eisaku
    Nagashima, Hiromi
    Nakamura, Atsushi
    Sugawara, Shunichi
    Tanaka, Nobuyuki
    Terasaki, Hiroshi
    Fukuhara, Tatsuro
    Maemondo, Makoto
    CANCERS, 2023, 15 (17)
  • [28] Use of Digital Droplet PCR for Detecting EGFR T790M Resistance Mutation in Plasma at Progression on TKI Therapy
    Jonsson, M.
    Planck, M.
    Reutersward, C.
    Nilsson, I.
    Carlsson, M.
    George, A.
    Saal, L.
    Staaf, J.
    Isaksson, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1037 - S1038
  • [29] Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA
    Remon, J.
    Caramella, C.
    Jovelet, C.
    Lacroix, L.
    Lawson, A.
    Smalley, S.
    Howarth, K.
    Gale, D.
    Green, E.
    Plagnol, V.
    Rosenfeld, N.
    Planchard, D.
    Bluthgen, M. V.
    Gazzah, A.
    Pannet, C.
    Nicotra, C.
    Auclin, E.
    Soria, J. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 784 - 790
  • [30] A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    Jin, Ying
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1211 - S1211
12345